BDBM50061847 (S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimidoyl-benzofuran-2-carbonyl)-amino]-propionylamino}-propionic acid::CHEMBL137639

SMILES CCCCS(=O)(=O)N[C@@H](CNC(=O)CCNC(=O)c1cc2cc(ccc2o1)C(N)=N)C(O)=O

InChI Key InChIKey=KCZDQEZSAWQHPZ-AWEZNQCLSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50061847   

TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061847((S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimid...)
Affinity DataIC50:  2nMAssay Description:Inhibitory activity of fibrinogen binding to purified immobilized glycoprotein (fibrinogen receptor).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIntegrin alpha-IIb/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061847((S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimid...)
Affinity DataIC50:  35nMAssay Description:Inhibition of platelet aggregation induced by 20 microM adenosine 5'-diphosphate (ADP) in human platelet rich plasma (h-PRP).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIntegrin alpha-V/beta-3(Human)
Cor Therapeutics

Curated by ChEMBL
LigandPNGBDBM50061847((S)-2-(Butane-1-sulfonylamino)-3-{3-[(5-carbamimid...)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of vitronectin binding to the purified immobilized vitronectin receptor (alpha v, beta 3).More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed